Start Date
May 24, 2018
Primary Completion Date
April 25, 2021
Study Completion Date
August 20, 2025
BMS-986205
Administered orally daily, 100 mg
Nivolumab
Specified dose on specified days
Chemotherapy
Platinum-based doublet chemotherapy
Local Institution, Vienna
Local Institution, Darlinghurst
Local Institution, North Tamworth
Local Institution, Melbourne
Local Institution, Basel
Local Institution, Brisbane
Local Institution, Wels
Local Institution, Murdoch
Local Institution, Taipei
Local Institution, Athens
Local Institution, Berlin
Local Institution, A Coruña
Local Institution, Gettysburg
Local Institution, Athens
Local Institution, Monza (MB)
Local Institution, Hamburg
Local Institution, Großhansdorf
Local Institution, Besançon
Local Institution, Oldenburg
Local Institution, Madrid
Local Institution, Majadahonda - Madrid
Local Institution, Málaga
Local Institution, Greenville
Local Institution, Decatur
Local Institution, Marietta
Local Institution, Jacksonville
Local Institution, Tallahassee
Local Institution, Paderborn
Local Institution, West Palm Beach
Local Institution, Pessac
Local Institution, St. Petersburg
Local Institution, Fort Myers
Local Institution, Istanbul
Local Institution, ?stanbul
Local Institution, Rennes
Local Institution, Göttingen
Local Institution, Lebanon
Local Institution, La Tronche
Local Institution, Louisville
Local Institution, Modena
Local Institution, Reggio Emilia
Local Institution, Cleveland
Local Institution, Saint-Herblain
Local Institution, Valencia
Local Institution, Ravenna
Local Institution, Bridgeton
Local Institution, Wiesbaden
Local Institution, Wichita
Local Institution, Lincoln
Local Institution, Heidelberg
Local Institution, Pringy
Local Institution, Paris
Local Institution, Fort Worth
Local Institution, Napoli
Local Institution, Gauting
Local Institution, Toulon
Local Institution, San Diego
Local Institution, Mérida
Local Institution, Osaka-sayama-shi
Local Institution, Fukushima
Local Institution, Boston
Local Institution, Lubbock
Local Institution, Ipatinga
Local Institution, Jd. Petropolis-Londrina
Local Institution, Centro-porto Alegre
Local Institution, Ijuí
Local Institution, Porto Alegre
Local Institution, Barretos
Local Institution, Morumbi
Local Institution, Rio de Janeiro
Local Institution, Québec
Local Institution, Prague
Local Institution, Gera
Local Institution, Thessaloniki
Local Institution, Perugia
Local Institution, Morioka
Local Institution, Kitaadachi-gun
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Barcelona
Local Institution, Taipei
Local Institution, Adana
Local Institution, Antalya
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY